Clinical end point acceptance limit [Study As­sess­ment]

posted by ElMaestro  – Belgium?, 2019-04-05 08:51  – Posting: # 20126
Views: 1,098

Hello to you too, PKS,

» Should I conclude bio-equivalence with the values of [-0.2025, 0.076] in clinical end point study. Can I assume it as within the interval of (-0.20, 0.20)

What does your protocol say on exactly that matter?

I could be wrong, but...
Best regards,
ElMaestro

Complete thread:

Activity
 Admin contact
20,138 posts in 4,246 threads, 1,386 registered users;
online 8 (1 registered, 7 guests [including 5 identified bots]).
Forum time (Europe/Vienna): 17:51 CET

It is better to debate a question without settling it
than to settle a question without debating it.    Joseph Joubert

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5